查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1901565

生物指标市场：依产品、方法、最终用途、国家及地区划分－全球产业分析、市场规模、市场占有率及2025-2032年预测

Biological Indicators Market, By Product, By Method, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年生物指标市场规模价值为 5.3289 亿美元，从 2025 年到 2032 年将以 8.5% 的复合年增长率成长。

生物指示剂是一种利用细菌孢子等高耐受性微生物直接检测灭菌处理效果的测试工具。它透过使指示孢子失活来确保蒸气或气体等灭菌处理已彻底杀灭所有可能有害的病菌。生物指示剂是检测灭菌效果的最佳方法，因为它能直接显示灭菌方法是否杀灭了目标微生物，而不仅是显示灭菌循环的各项参数均已达到要求。医疗保健和製药业对灭菌验证的监管要求日益严格，以及全球范围内对感染控制和安全标准的日益重视，推动了生物指标市场的成长。然而，与化学指示剂相比，生物指标的高昂成本是限制其产业发展的主要挑战。

生物指示剂市场－市场动态

製药和生物製药製造业的成长推动了市场成长。

由于越来越多的製药和生物製药企业需要在生产过程中保持产品的清洁无污染，生物指标市场正在蓬勃发展。随着这些领域的成长，无菌药物、疫苗和生物製剂的生产需要对灭菌方法进行严格的测试，以确保产品的安全性和有效性。生物指示剂在确保灭菌技术能有效杀死细菌方面尤其重要。这对于遵守相关指南和保障病人安全至关重要。随着更先进的生物製剂和个人化疗法的出现，对可靠的灭菌监测的需求不断增长，从而推动了市场扩张。此外，製药和生物製药生产行业日益严格的法律法规和更高的品质标准表明，先进的生物指标仍将发挥重要作用。这将使该细分市场保持旺盛的需求。

生物指示剂市场区隔分析：

全球市场按产品、方法、最终用途和地区进行细分。

根据产品类型，自封式（小瓶/安瓿）在基准年占据最大的市场份额。孢子载体和培养基合而为一的设计使其易于使用、安全便捷，从而促进了其市场扩张。这种设计使製药企业和医疗机构能够轻鬆确保其灭菌流程的有效性，从而提高其可靠性和效率。预计未来几年，自封式灭菌产品产业将以最快的速度成长，因为它能够提供精确的结果并简化操作。这是因为人们对快速简便的灭菌监测方法的需求日益增长。

根据灭菌方法，蒸气灭菌在预测期内将占据最大的收入份额。其成长的原因在于蒸气灭菌有效、安全且成本低廉，能够彻底清除抗药性细菌。它仍然是医院清洁手术器械、实验室清洁可重复使用的玻璃器皿以及製药业清洁生产设备和培养基的最常用方法。蒸气灭菌高压灭菌器广泛应用于手术室及中央消毒供应室（CSSD），以保障病人安全。此外，蒸气灭菌也是药品生产过程中的常见步骤，确保生产过程清洁并符合严格的规范。由于蒸气灭菌用途广泛且有完善的规范，因此一直是首选的灭菌方法。

生物指示剂市场—地理洞察

生物指标市场呈现出显着的地域差异，这主要受政府严格监管和製药业蓬勃发展的推动。亚太地区是该市场成长最快的地区，其成长主要归功于製药业的快速扩张和医院感染率的上升，尤其是中国、日本、韩国和印度等国家。该地区的领先製造商正积极推出新产品以满足不断增长的需求。北美地区继续主导市场成长，这得益于其成熟的製药和生物製药行业，以及该地区众多知名企业的存在。拉丁美洲、中东和非洲等新兴地区也在医疗基础建设的完善和政府支持的加强下，逐渐扩大市场份额。

美国生物指示剂市场—国家概况

在北美，美国市场在预测期内将以惊人的速度成长。美国市场的成长归因于许多因素，例如医院感染（HAI）的增加以及辉瑞、雅培等众多知名製药公司的存在。例如，美国疾病管制与预防中心（CDC）的报告指出，到2023年，美国医院重症监护室（ICU）患者中约有19.5%至少感染过一种医院感染，这凸显了消毒监测的关键作用。

此外，包括数位化监控系统和自动化灭菌操作在内的技术进步，正使生物指示剂更加可靠有效。同时，对感染控制和病人安全的日益重视，也促使医疗机构采用更先进的灭菌验证技术，进一步推动了市场的发展。

目录

第一章：生物指示剂市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
  • 竞争洞察

第三章：生物指标主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场未来趋势

第四章：生物指示剂产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：生物指标市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：生物指示剂市场概况

  • 生物指示剂市场占有率分析，2024年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：生物指示剂市场：依产品分类

  • 概述
    • 细分市场占有率分析：依产品划分
    • 自封式（小瓶/安瓿）
    • 条状物
    • 卡片/快速读取BIS
    • 其他的

第八章：生物指标市场：依方法划分

  • 概述
    • 细分市场占有率分析：依方法
    • 蒸气灭菌
    • 环氧乙烷灭菌
    • 过氧化氢灭菌
    • 辐照灭菌（伽玛射线、电子束）
    • 干热灭菌

第九章：生物指示剂市场：依最终用途划分

  • 概述
    • 医院和诊所（CSSD/感染控制部门）
    • 门诊手术中心（ASC）和牙科诊所
    • 生物製药和生物技术公司
    • 医疗器材製造商
    • 合约灭菌服务提供者
    • 研究与学术机构
    • 其他的

第十章：生物指标市场：依地域划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • その他
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • その他
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • その他

第十一章：主要供应商分析：生物指标产业

  • 竞争格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Mesa Labs, Inc.
    • LISTER BioMedical
    • STERIS plc.
    • Solventum
    • Getinge
    • 3M
    • Terragene SA
    • Propper Manufacturing Co., Inc.
    • Tuttnauer
    • Ecolab Inc.
    • HWAndersen Products Ltd.
    • MATACHANA GROUP
    • Liofilchem Srl
    • Steelco SpA
    • Zhejiang Tailin Bioengineering Co., Ltd.

第12章：全面展望

简介目录
Product Code: ANV5899

The Biological Indicators Market size was valued at US$ 532.89 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.

A biological indicator is a test tool that uses very resistant microorganisms, like bacterial spores, to directly check how well a sterilizing treatment works. It is used to make sure that a sterilizing treatment, like steam or gas, has killed all germs that could be harmful by making the indicator spores inactive. Biological indicators are the best way to check if sterilization worked since they show that the approach killed the right microbes instead of just showing that the parameters for a sterilization cycle were met. The market growth is driven by the increasing regulatory requirements for sterilization validation in healthcare and pharmaceutical industries, as well as rising awareness about infection control and safety standards worldwide. However, the high cost compared to chemical indicators poses a major challenge to the industry growth.

Biological Indicators Market- Market Dynamics

Growth of the pharmaceutical & biopharmaceutical manufacturing drives the market growth

The biological indicators market is rising because more pharmaceutical and biopharmaceutical businesses need to keep their goods clean and free of contamination while they are being made. As these fields grow, making sterile drugs, vaccines, and biologics requires strict testing of sterilization methods to make sure the products are safe and work. Biological indicators are particularly useful for making sure that sterilization techniques get rid of germs. This is vital to obey the guidelines and keep patients safe. The demand for reliable sterilization monitoring has grown as more advanced biologic medications and personalized therapy have become available. This has led to market expansion. Also, stiffer laws and higher quality standards in the pharmaceutical and biopharmaceutical production industries indicate that advanced biological markers will still be needed. This will maintain this market segment in high demand.

Biological Indicators Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Product, Method, End Use and Region.

Based on the product, the self-contained (vials/ampoules) holds the largest market share in the base year. The fact that the spore carrier and growing media are combined into one unit makes it easy to use, safe, and convenient, which has led to its expansion. This design makes it easy for pharmaceutical businesses and healthcare facilities to make sure that their sterilizing processes are working. This makes them more reliable and efficient. The self-contained industry is predicted to grow the fastest over the next few years because it can give precise results and make operations easier. This is because there is a rising need for quick and easy ways to keep an eye on sterilization.

Based on the method, the steam sterilization segment holds the largest revenue share over the forecast period. This growth is because it works, is safe, and is cheap to get rid of bacteria that are resistant. It is still the most frequent approach to clean surgical tools in hospitals, glassware that may be used again in labs, and manufacturing equipment and culture medium in the pharmaceutical business. Steam sterilization autoclaves are widely used in operating rooms and central sterile supply departments (CSSDs) to keep patients safe. Also, steam sterilization is a common part of making drugs to make sure that the processes are clean and follow stringent guidelines. Since it may be used in so many various ways and is backed by rules, steam sterilization has been the most preferred approach.

Biological Indicators Market- Geographical Insights

The Biological Indicators market shows significant geographical variation, driven by the strict rules imposed by the government and growing pharmaceutical sector. The Asia Pacific experiencing a fastest growth in the market. Growth is due to rapid expansion in pharmaceutical sector and increasing HAI, especially in countries like China, Japan, South Korea, and India. Leading manufacturers in this region actively launch new products to cater to this surging demand. North America continues to dominate the market growth. It is propelled by the established pharmaceutical and biopharmaceutical sector. In addition, the presence of established player in the area. Emerging regions such as Latin America, the Middle East, and Africa are gradually growing their footprint, fueled by expansion of healthcare infrastructure and the increasing government support.

US Biological Indicators Market- Country Insights

In North America, the US market is growing at a staggering rate over the projected period. The growth of the market in the US is attributed to the number of factors such as increasing HAI and the presence of established pharmaceutical sector such as Pfizer, Abbott and many others. For instance, a CDC report highlighted that in 2023, approximately 19.5% of ICU patients across U.S. hospitals had at least one HAI, emphasizing the critical role of sterilization monitoring.

Also, technological improvements, including adding digital monitoring systems and automating sterilizing operations, are making biological indicators more reliable and effective. Also, the increased focus on infection control and patient safety is pushing healthcare facilities to use more modern sterilization validation technologies, which is helping the market develop even more.

Biological Indicators Market- Competitive Landscape:

The biological indicators market will have both big, well-known companies and smaller, more specialized ones in 2024. Some of the best companies that will be competing are 3M, Getinge Group, and Steris. These firms set the norm by creating biological markers that are high-tech, easy to use, and reliable. These indicators usually come with quick-readout and automatic solutions to help with productivity and obeying the laws. The market is getting more competitive because more and more individuals require cheap ways to check for sterilization. This is because of strict laws and the surge in infections that happen in hospitals and other healthcare settings (HAIs). Companies in the market want to take advantage of opportunities for growth, therefore one of their main strategies is to go into new areas, especially in countries that are booming, like Asia-Pacific. North America and Europe's economies are still the strongest because they have well-developed healthcare systems and tight rules. But investments in the health care and drug industries ensure that new markets have a lot of room to grow. There are restrictions on the market, such as the high costs of advanced indicators and the fact that there are other ways to keep an eye on sterilization. But new ideas and strong partnerships are still what keeps the sector developing and businesses competitive.

Recent Developments:

In April 2024, 3M finalized the spin-off of its healthcare division, officially launching Solventum Corporation as an independent entity. The company is now listed on the New York Stock Exchange under the ticker symbol SOLV.

In June 2025, Solventum introduced its Attest Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack. This ready-to-use test combines two previously FDA-cleared indicators, a biological indicator (BI) for verifying microbial inactivation and a chemical indicator (CI) for confirming proper sterilizer function, into a single-use pack with a transparent container for easy and reliable sterilization validation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICAL INDICATORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Mesa Labs, Inc.
  • LISTER BioMedical
  • STERIS plc.
  • Solventum
  • Getinge
  • 3M
  • Terragene S.A.
  • Propper Manufacturing Co., Inc.
  • Tuttnauer
  • Ecolab Inc.
  • H.W.Andersen Products Ltd.
  • MATACHANA GROUP
  • Liofilchem S.r.l.
  • Steelco S.p.A
  • Zhejiang Tailin Bioengineering Co., Ltd.

GLOBAL BIOLOGICAL INDICATORS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Self-Contained (Vials/Ampoules)
  • Strips
  • Cards / Rapid Readout Bis
  • Others

GLOBAL BIOLOGICAL INDICATORS MARKET, BY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Steam Sterilization
  • Ethylene Oxide Sterilization
  • Hydrogen Peroxide Sterilization
  • Irradiation Sterilization (Gamma, E-beam)
  • Dry Heat Sterilization

GLOBAL BIOLOGICAL INDICATORS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics (CSSD / Infection Control Units)
  • Ambulatory Surgery Centers (ASCs) & Dental Clinics
  • Biopharma & Biotech Companies
  • Medical Device Manufacturers
  • Contract Sterilization Service Providers
  • Research & Academic Institutes
  • Others

GLOBAL BIOLOGICAL INDICATORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biological Indicators Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biological Indicators Market Snippet by Product
    • 2.1.2. Biological Indicators Market Snippet by Method
    • 2.1.3. Biological Indicators Market Snippet by End Use
    • 2.1.4. Biological Indicators Market Snippet by Country
    • 2.1.5. Biological Indicators Market Snippet by Region
  • 2.2. Competitive Insights

3. Biological Indicators Key Market Trends

  • 3.1. Biological Indicators Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biological Indicators Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biological Indicators Market Opportunities
  • 3.4. Biological Indicators Market Future Trends

4. Biological Indicators Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biological Indicators Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Biological Indicators Market Landscape

  • 6.1. Biological Indicators Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biological Indicators Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024&2032 (%)
    • 7.1.2. Self-Contained (Vials/Ampoules)
    • 7.1.3. Strips
    • 7.1.4. Cards / Rapid Readout Bis
    • 7.1.5. Others

8. Biological Indicators Market - By Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Method, 2024&2032 (%)
    • 8.1.2. Steam Sterilization
    • 8.1.3. Ethylene Oxide Sterilization
    • 8.1.4. Hydrogen Peroxide Sterilization
    • 8.1.5. Irradiation Sterilization (Gamma, E-beam)
    • 8.1.6. Dry Heat Sterilization

9. Biological Indicators Market - By End Use

  • 9.1. Overview
    • 9.1.1. Hospitals & Clinics (CSSD / Infection Control Units)
    • 9.1.2. Ambulatory Surgery Centers (ASCs) & Dental Clinics
    • 9.1.3. Biopharma & Biotech Companies
    • 9.1.4. Medical Device Manufacturers
    • 9.1.5. Contract Sterilization Service Providers
    • 9.1.6. Research & Academic Institutes
    • 9.1.7. Others

10. Biological Indicators Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biological Indicators Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biological Indicators Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biological IndicatorsKey Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Biological Indicators Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Biological IndicatorsKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Biological Indicators Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Mesa Labs, Inc.
    • 11.2.2. LISTER BioMedical
    • 11.2.3. STERIS plc.
    • 11.2.4. Solventum
    • 11.2.5. Getinge
    • 11.2.6. 3M
    • 11.2.7. Terragene S.A.
    • 11.2.8. Propper Manufacturing Co., Inc.
    • 11.2.9. Tuttnauer
    • 11.2.10. Ecolab Inc.
    • 11.2.11. H.W.Andersen Products Ltd.
    • 11.2.12. MATACHANA GROUP
    • 11.2.13. Liofilchem S.r.l.
    • 11.2.14. Steelco S.p.A
    • 11.2.15. Zhejiang Tailin Bioengineering Co., Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us